OBI Pharma Inc. to attend Credit Suisse Asian Investment Conference
1. Date of the event: 2018/03/21 2. Time: 08:30:00 TST 3. Location：Conrad Hong Kong 4. Summary: OBI Pharma Inc. to attend Credit Suisse Italy Med Conference 5. Any other matters …
Announcement on the Change of Chief Financial Officer
Type of personnel changed (please enter: spokesperson, acting spokesperson, important operational officer, financial officer, accounting officer, research and development officer, or internal audit officer): Financial Officer Date of occurrence of …
OBI Pharma’s Board of Directors approves the announcement of the Company’s 2017 individual and consolidated financial statements
1. Date of occurrence of the event: 2018/03/09 2. Company name: OBI Pharma, Inc 3. Relationship to the Company (please enter “head office” or “subsidiaries”):Parent 4. Reciprocal shareholding ratios: N/A …
The board of directors have resolved 2017 not to distribute dividends
Date of the board of directors resolution:2018/03/09 Appropriations of earnings in cash dividends to shareholders (NT$ per share):0 Cash dividends distributed from legal reserve and capital reserve to shareholders (NT$ …
The Board of Directors resolved to hold 2018 Annual General Meeting
Date of the board of directors resolution: Mar 09, 2018 Date for convening the shareholders’ meeting: Jun 27, 2018 Location for convening the shareholders’ meeting: Masterlink Securities Education and Training …
Clarification on the news articles by Commercial Times, United Daily, etc.
Date of occurrence of the event:2018/02/23 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding ratios: N/A Name of mass …
OBI Pharma Announces FDA Clearance Of IND Application For A Phase 1 Study Of A Monoclonal Antibody Cancer Immunotherapy (OBI-888)
First Clinical Trial to Test the Safety and Preliminary Activity of Passive Immunotherapy based on a Monoclonal Antibody targeting Globo H, a glycolipid antigen found on multiple tumor types. Taipei, …
FDA Clearance of IND Application for A Phase 1 Study of A Monoclonal Antibody Cancer Immunotherapy (OBI-888)
Date of occurrence of the event: January 17, 2018 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): Head office Reciprocal shareholding ratios: …
Shilin District Court deny OBI’s request to submit the case for trial
Defendant: Reporter Pei amongst the other six reporters Name of the legal agency or court: Taiwan Shilin District Court Reference/case numbers of relevant documents: 2017 Sheng Pan Zi, No. 72 …
OBI Pharma Inc. to attend the investor conference on new drug development, hosted by Masterlink Securities
Date: January 16, 2018 Date of the event: Jan 16, 2018 Time: 14:00:00 (Taiwan Time) Location：Courtyard Marriott Taipei Summary: OBI Pharma Inc. to attend the investor conference on new drug …